Keyphrases
Intraocular Pressure
100%
Aqueous Humor Dynamics
100%
C-type Natriuretic Peptide
100%
Peptide Analogs
100%
Primary Open-angle Glaucoma
50%
Ocular Hypertension
37%
NPR-B
37%
Amino Acids
25%
IC50
25%
EC50
25%
Aqueous Outflow Facility
25%
Cornea
25%
Formation Rate
25%
Natriuretic Peptide Receptor
25%
Trabecular Meshwork Cells
12%
Aqueous Humor Outflow
12%
Outflow Facility
12%
Mechanism of Action
12%
Treatment Mechanisms
12%
Novel Mechanism
12%
Uveoscleral Outflow
12%
Irreversible Blindness
12%
Aqueous Humor Formation
12%
Receptor Binding
12%
HEK293 Cells
12%
Pharmacologic
12%
Modifiable Risk Factors
12%
Cyclic Peptide
12%
Cyclic GMP
12%
Ligand Binding
12%
Angiotensin II Type 1 Receptor (AT1R)
12%
Topical Ophthalmic Administration
12%
Binding Profile
12%
Intraocular Injection
12%
Ocular Hypotension
12%
Episcleral Venous Pressure
12%
Glaucoma Progression
12%
Duration of Action
12%
Disease Management
12%
B-type Natriuretic Peptide
12%
Cholecystokinin Receptor
12%
Ocular Side Effects
12%
Outflow Rate
12%
Pressure Decrease
12%
Natural Agonists
12%
GMP Production
12%
NPR-A
12%
Pharmacology, Toxicology and Pharmaceutical Science
Open Angle Glaucoma
100%
Natriuretic Peptide Type C
100%
Intraocular Hypertension
75%
Receptor
75%
Amino Acid
50%
IC50
50%
EC50
50%
Glaucoma
25%
Adverse Event
25%
Disease
25%
Antihypertensive Agent
25%
Cyclic GMP
25%
Cyclopeptide
25%
Natriuretic Peptide Receptor B
25%
Natriuretic Factor
25%
Angiotensin 2 Receptor
25%
Cholecystokinin A Receptor
25%
Medicine and Dentistry
Intraocular Pressure
100%
Aqueous Humor Flow
100%
Natriuretic Peptide Type C
100%
Open Angle Glaucoma
50%
Aqueous Humor Outflow
37%
Ocular Hypertension
37%
IC50
25%
Amino Acid
25%
Trabecular Meshwork
12%
Aqueous Humor Formation
12%
Adverse Event
12%
Receptor
12%
In Vitro
12%
Antihypertensive Agent
12%
Venous Pressure
12%
Disease Management
12%
Natriuretic Factor
12%
Receptor Binding
12%
Ligand Binding
12%
Risk Factor for Glaucoma
12%
Cyclic GMP
12%
Natriuretic Peptide Receptor B
12%
Intraocular Drug Administration
12%
Peptide Receptor
12%
Cholecystokinin A Receptor
12%
Angiotensin II Receptor Type 2
12%
Cyclopeptide
12%